19-15181626-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000435.3(NOTCH3):​c.2742A>G​(p.Pro914Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.845 in 1,551,032 control chromosomes in the GnomAD database, including 557,175 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 46354 hom., cov: 34)
Exomes 𝑓: 0.85 ( 510821 hom. )

Consequence

NOTCH3
NM_000435.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -9.66

Publications

32 publications found
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]
NOTCH3 Gene-Disease associations (from GenCC):
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral meningocele syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myofibromatosis, infantile, 2
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 19-15181626-T-C is Benign according to our data. Variant chr19-15181626-T-C is described in ClinVar as Benign. ClinVar VariationId is 256130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.66 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.858 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH3NM_000435.3 linkc.2742A>G p.Pro914Pro synonymous_variant Exon 17 of 33 ENST00000263388.7 NP_000426.2 Q9UM47
NOTCH3XM_005259924.5 linkc.2586A>G p.Pro862Pro synonymous_variant Exon 16 of 32 XP_005259981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH3ENST00000263388.7 linkc.2742A>G p.Pro914Pro synonymous_variant Exon 17 of 33 1 NM_000435.3 ENSP00000263388.1 Q9UM47
NOTCH3ENST00000601011.1 linkc.2583A>G p.Pro861Pro synonymous_variant Exon 16 of 23 5 ENSP00000473138.1 M0R3C9

Frequencies

GnomAD3 genomes
AF:
0.773
AC:
117486
AN:
152050
Hom.:
46335
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.606
Gnomad AMI
AF:
0.742
Gnomad AMR
AF:
0.724
Gnomad ASJ
AF:
0.840
Gnomad EAS
AF:
0.825
Gnomad SAS
AF:
0.804
Gnomad FIN
AF:
0.846
Gnomad MID
AF:
0.826
Gnomad NFE
AF:
0.864
Gnomad OTH
AF:
0.771
GnomAD2 exomes
AF:
0.803
AC:
124202
AN:
154616
AF XY:
0.809
show subpopulations
Gnomad AFR exome
AF:
0.593
Gnomad AMR exome
AF:
0.685
Gnomad ASJ exome
AF:
0.834
Gnomad EAS exome
AF:
0.810
Gnomad FIN exome
AF:
0.845
Gnomad NFE exome
AF:
0.866
Gnomad OTH exome
AF:
0.804
GnomAD4 exome
AF:
0.853
AC:
1192826
AN:
1398864
Hom.:
510821
Cov.:
68
AF XY:
0.852
AC XY:
587831
AN XY:
690034
show subpopulations
African (AFR)
AF:
0.600
AC:
18985
AN:
31622
American (AMR)
AF:
0.689
AC:
24598
AN:
35726
Ashkenazi Jewish (ASJ)
AF:
0.835
AC:
21019
AN:
25170
East Asian (EAS)
AF:
0.850
AC:
30400
AN:
35758
South Asian (SAS)
AF:
0.807
AC:
63968
AN:
79262
European-Finnish (FIN)
AF:
0.849
AC:
41196
AN:
48542
Middle Eastern (MID)
AF:
0.784
AC:
4467
AN:
5696
European-Non Finnish (NFE)
AF:
0.872
AC:
940579
AN:
1079076
Other (OTH)
AF:
0.821
AC:
47614
AN:
58012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
10397
20794
31190
41587
51984
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20888
41776
62664
83552
104440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.772
AC:
117547
AN:
152168
Hom.:
46354
Cov.:
34
AF XY:
0.772
AC XY:
57409
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.606
AC:
25150
AN:
41502
American (AMR)
AF:
0.723
AC:
11060
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.840
AC:
2916
AN:
3472
East Asian (EAS)
AF:
0.826
AC:
4262
AN:
5162
South Asian (SAS)
AF:
0.804
AC:
3884
AN:
4830
European-Finnish (FIN)
AF:
0.846
AC:
8965
AN:
10596
Middle Eastern (MID)
AF:
0.816
AC:
240
AN:
294
European-Non Finnish (NFE)
AF:
0.864
AC:
58766
AN:
67998
Other (OTH)
AF:
0.771
AC:
1629
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1319
2638
3958
5277
6596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
862
1724
2586
3448
4310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.822
Hom.:
27229
Bravo
AF:
0.756
Asia WGS
AF:
0.798
AC:
2772
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 14, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 16, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Lateral meningocele syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.014
DANN
Benign
0.28
PhyloP100
-9.7
Mutation Taster
=76/24
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1043997; hg19: chr19-15292437; COSMIC: COSV54638490; COSMIC: COSV54638490; API